Dare Bioscience (DARE)
(Real Time Quote from BATS)
$0.46 USD
+0.02 (4.95%)
Updated Jun 7, 2024 10:58 AM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Dare Bioscience, Inc. [DARE]
Reports for Purchase
Showing records 181 - 200 ( 213 total )
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Thinking Several Steps Ahead with Optimizing IVR Quality Control
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Let?s Talk About Women?s Health-TRANSFER OF COVERAGE
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Recap of 22 Expert Calls in 2018 - 2019 for Our Coverage Universe
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
1Q19 - Pivotal Year Ahead: Advancing Women''s Health on All Fronts
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Yas'' Weekly Recap - What the Buy-side Reads
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Continuing to Build Its Women''s Health Pipeline
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Yas'' Weekly Recap - What the Buy Side Reads
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
3Q18 - Making Headway in Sildenafil Cream and Ovaprene Phase 2 Programs
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Dare Bioscience, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.